• SENSEX 75,617.88
    -677.48 (--0.89%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Infosys
    1,451.50 1,359.10(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • Vodafone Idea
    7.85 6.60(%)
  • TCS
    3,307.55 3,396.10(%)
  • Jio Financial
    222.30 198.60(%)
  • Angel One
    2,317.80 1,942.00(%)
  • O N G C
    225.70 215.20(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • IndusInd Bank
    675.40 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Norris Medicines Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3347.0
  • ISIN : INE744C01029
16.27 0 (-0.43%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    15.73

  • Today’s High

    16.35

  • Open

    16.34

  • Perv Close

    16.34

  • 52W Low

    10.70

  • 52W High

    27.74

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    16.27

  • Div & Yield %

    0.00

  • Book Value(₹)

    -14.28

  • Debt-Equity Ratio

    -0.43

  • AGM Date

    03-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    16.27

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.00

  • BV (₹)

    -14.30

  • Sales( ₹ in Cr.)

    5.64

  • NP (in Cr.)

    -1.17

  • NP Var(%)

    33.0

  • Div%

    0.0

  • CPS (₹)

    -0.60

  • EPS (₹)

    -1.20

  • Traded Value (₹ in Lakhs)

    16.27

  • 52 Week High

    27.74

  • 52 Week Low

    10.70

  • Price BSE

    16.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    16.27

  • P/C Ratio

    -26.90

  • P/E Ratio

    -13.70

  • Price Vs.BV

    -1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 5.64 8.36 9.44 12.25 7.90 16.34
Excise Duty 5.22 7.81 8.84 11.62 6.44 14.65
Net Sales 5.64 8.36 9.44 12.25 7.90 16.34
Other Income 0.03 0.01 0.03 0.05 0.09 0.04
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 5.66 8.37 9.46 12.30 7.93 16.31
EXPENDITURE :
Raw Materials 5.22 7.81 8.84 11.62 6.44 14.65
Power & Fuel Cost 5.22 7.81 8.84 11.62 6.44 14.65
Employee Cost 1.82 2.30 2.33 3.10 3.23 3.81
Other Manufacturing Expenses 0.05 0.06 0.09 0.13 0.00 0.01
Selling & Administrative Expenses 0.35 0.44 0.40 0.68 0.56 0.73
Miscellaneous Expenses 0.05 0.06 0.09 0.13 0.00 0.01
Less : Pre-operative Expenses Capitalised :
Total Expenditure 6.76 9.57 11.65 16.30 11.61 18.32
Operating Profit 0.95 1.27 1.09 1.34 1.69 2.15
Interest 0.37 1.50 1.48 1.63 0.88 0.73
Gross Profit -1.10 -1.19 -2.18 -3.99 -3.68 -2.01
Depreciation 0.57 0.63 0.66 0.67 0.73 0.71
Profit Before Tax -1.10 -1.19 -2.18 -3.99 -3.68 -2.01
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.09 0.56 1.08 0.97 0.00 0.00
Reported Net Profit -1.19 -1.75 -3.26 -4.96 -2.84 -1.68
Extraordinary Items -1.10 -1.19 -2.18 -3.99 -3.68 -2.01
Adjusted Net Profit -1.19 -1.75 -3.26 -4.96 -2.84 -1.68
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.19 -1.75 -3.26 -4.96 -2.84 -1.68
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.19 -1.75 -3.26 -4.96 -2.84 -1.68
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    34.00%

  • Public Share Holding

    66.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,000,000 10.00 1,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,400,131 24.00 2,398,631 4
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,400,131 34.00 3,398,631 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,420 0.06 6,420 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 510 0.01 0 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,930 0.07 6,420 6
2] Non Institution
Bodies Corporate 4,394,522 43.94 4,394,522 61
Clearing Members 39,036 0.39 39,036 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 42,228 0.42 42,228 52
Foreign Non Institution Other 27,150 0.27 27,150 2
Hindu Undivided Families 17,753 0.18 17,753 60
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 27,480 0.27 27,480 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,045,282 20.45 766,499 25,466
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 90 0.00 90 1
Others 0 0.00 0 0
Sub Total 6,593,639 65.93 5,314,856 25,648
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,000,700 100.00 8,719,907 25,659

Company Background

Norris Medicines LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Norris Medicines Ltd
  • BSE Code : 3347.0
  • ISIN : INE744C01029

  • Incorporation Year

    1990

  • Registered Office

    Plot No 801/P & 802
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-223462/227530

  • FAX

    91-2646-250126

  • Chairman

  • Managing Director

    Vimal D Shah

  • Company Secretary

    Priyanka Lohiya

  • Auditor

    Bahedia & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Norris Medicines Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Norris Medicines 16.27 5.66 5.64 -19.60 0.00
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92